readthroughSign in
CompanyEVAXNasdaqHoersholm

Evaxion Biotech A/S

Evaxion Biotech develops personalized and off-the-shelf cancer vaccines and prophylactic vaccines for infectious diseases using its AI-Immunology platform.

424B3Nov 13Latest SEC filing
Nov 12Latest story